99%+ Purity Oral Pill & Tablet Orlistat Raw Powders
Orlistat Characteristics | |
Manufacturer | HKYCGC |
CAS No. | 96829-58-2 |
Assay | 99% |
Package | 1kg/foil bag,5kg/bag,25kg/drum |
Synonym | RO-18-0647 |
Minimum order | 10g |
99%+ Purity Oral Pill & Tablet Orlistat Raw Powders
Orlistat Details:
Orlistat
Synonym: N-FORMYL-L-LEUCINE (1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYL ESTER;;(-)-Tetrahydrolipstatin(EquivalentToOrlistat);Orlipastat
CAS: 96829-58-2
MF: C29H53NO5
MW: 495.73
Assay: 99%
Appearance: White powder
Package: foil bag
Orlistat Specifications:
COA:
Test Items | Specifications |
| Appearance | White or almost white crystalline powder |
| Specific Rotation | -48° ~ -51.0°(on the anhydrous, solvent-free basis) |
| Identification | A.HPLC: The retention time of the major peak of the sample solution corresponds to that of the standard solution. |
| B.IR: The IR spectrum of sample is consistent to the reference | |
| Related Substances | |
| Total impurity | Not more than 1.0% |
| Related Compound A | Not more than 0.2% |
| Related Compound B | Not more than 0.05% |
| Related Compound C | Not more than 0.05% |
| Related Compound D | Not more than 0.2% |
| Related Compound E | Not more than 0.2% |
| Formyl leucine | Not more than 0.2% |
| Orlistat open ring epimer | Not more than 0.2% |
| D-Leucine orlistat | Not more than 0.2% |
| Orlistat open ring amide | Not more than 0.1% |
| Individual unidentified impurity | Not more than 0.1% |
| Residual Solvents | |
| n-Hexane | Not more than 5000ppm |
| Isopropyl ether | Not more than 5000ppm |
| Residual on ignition | Not more than 0.1% |
| Heavy Metal | Not more than 20ppm |
| Water | Not more than 0.2% |
| Assay | 98.0%~101.5% (on the anhydrous, solvent-free basis) |
| Conclusion | Conform with USP35 or EP |
Orlistat Profile:
Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.
Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
We are the manufacturer of all kinds of hormone and steriod powders. We focus on providing customers with high quality products, competitive price, best service and timely delivery.
Orlistat Usage:
Orlistat is used for the treatment of obesity.The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body mass.After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
- Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.
- The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).
Our Advantages:
(1) High Quality: HONGKONG YUANCHENG GONGCHUANG TECHNOLOGY Co., LIMITED is a steroids manufacturer with its own lab and factory.
The purity of our product is tested by our quality department before it is shipped to our clients. Mostly steroids are 99% purity and approved by SGS,CTI and ITS.
(2) Favorable Price: Our price meets international market performance and we give the best doiscounted price for our new customers and promotioned price for our regular customers.
(3) Safe Fast Delivery: After receiving your payment,we will have professional package team to arrange your parcel within 12 hours.We can guarantee every goods can be successfully deliveried
(4) Available Shipment Way: EMS,HongKong Post,DHL,TNT,UPS,FedEx,Registered Mail,Air Express,Sea Vessel etc
(5) After-Sale Service: We can offer you good service after you place an order.At the same time,we can offer you some homebrew recipe to make injection.More service is more available to you.
